Kevin M. Picardat

Array ( [id] => 5171827 [patent_doc_number] => 20070072259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Fluorescent protein' [patent_app_type] => utility [patent_app_number] => 10/561040 [patent_app_country] => US [patent_app_date] => 2004-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9484 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072259.pdf [firstpage_image] =>[orig_patent_app_number] => 10561040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675801 [patent_doc_number] => 20080213430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Antimicrobial Peptides' [patent_app_type] => utility [patent_app_number] => 10/560260 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21011 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213430.pdf [firstpage_image] =>[orig_patent_app_number] => 10560260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264927 [patent_doc_number] => 20040242463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Compositions for stabilizing oxygen-labile species' [patent_app_type] => new [patent_app_number] => 10/856440 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5822 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242463.pdf [firstpage_image] =>[orig_patent_app_number] => 10856440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912931 [patent_doc_number] => 20060127993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Thiamin production by fermentation' [patent_app_type] => utility [patent_app_number] => 10/559307 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16862 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127993.pdf [firstpage_image] =>[orig_patent_app_number] => 10559307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939741 [patent_doc_number] => 20050113304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins' [patent_app_type] => utility [patent_app_number] => 10/854646 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10580 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113304.pdf [firstpage_image] =>[orig_patent_app_number] => 10854646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 948866 [patent_doc_number] => 06962902 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-08 [patent_title] => 'Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm' [patent_app_type] => utility [patent_app_number] => 10/848469 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10935 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/962/06962902.pdf [firstpage_image] =>[orig_patent_app_number] => 10848469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7228703 [patent_doc_number] => 20050255534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Method and device for monitoring asprin response' [patent_app_type] => utility [patent_app_number] => 10/846439 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6536 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255534.pdf [firstpage_image] =>[orig_patent_app_number] => 10846439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 737982 [patent_doc_number] => 07034126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Lactoferrin in the treatment of diabetes mellitus' [patent_app_type] => utility [patent_app_number] => 10/844865 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7964 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/034/07034126.pdf [firstpage_image] =>[orig_patent_app_number] => 10844865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 961129 [patent_doc_number] => 06951842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-04 [patent_title] => 'Compositions providing for increased IGF-I solubility' [patent_app_type] => utility [patent_app_number] => 10/843034 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7549 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951842.pdf [firstpage_image] =>[orig_patent_app_number] => 10843034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7056420 [patent_doc_number] => 20050277595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Method for treating a patient undergoing chemotherapy' [patent_app_type] => utility [patent_app_number] => 10/842877 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 12165 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277595.pdf [firstpage_image] =>[orig_patent_app_number] => 10842877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 428780 [patent_doc_number] => 07268215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-11 [patent_title] => 'Photoprotein derived from okinawan squid and gene encoding the photoprotein' [patent_app_type] => utility [patent_app_number] => 10/835180 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 5568 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/268/07268215.pdf [firstpage_image] =>[orig_patent_app_number] => 10835180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7461393 [patent_doc_number] => 20040197847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'High throughput screening assays using fatty acid synthetic enzymes' [patent_app_type] => new [patent_app_number] => 10/827668 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8032 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197847.pdf [firstpage_image] =>[orig_patent_app_number] => 10827668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6990847 [patent_doc_number] => 20050089884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Genes for synthesis of FR-008 polyketides' [patent_app_type] => utility [patent_app_number] => 10/819386 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10140 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089884.pdf [firstpage_image] =>[orig_patent_app_number] => 10819386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5069000 [patent_doc_number] => 20070190101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Flowable bone grafts' [patent_app_type] => utility [patent_app_number] => 10/815000 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5738 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190101.pdf [firstpage_image] =>[orig_patent_app_number] => 10815000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7345631 [patent_doc_number] => 20040247623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin' [patent_app_type] => new [patent_app_number] => 10/808008 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2001 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247623.pdf [firstpage_image] =>[orig_patent_app_number] => 10808008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7422556 [patent_doc_number] => 20040229312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Engineered human kunitz-type protease inhibitor' [patent_app_type] => new [patent_app_number] => 10/807204 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28594 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229312.pdf [firstpage_image] =>[orig_patent_app_number] => 10807204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625857 [patent_doc_number] => 20060264362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Method of modulating smooth muscle cell functioning by modulating sphingosine kinase mediated signalling' [patent_app_type] => utility [patent_app_number] => 10/549548 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17347 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264362.pdf [firstpage_image] =>[orig_patent_app_number] => 10549548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 737899 [patent_doc_number] => 07034107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'High throughput assays for the proteolytic activities of clostridial neurotoxins' [patent_app_type] => utility [patent_app_number] => 10/802574 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8201 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/034/07034107.pdf [firstpage_image] =>[orig_patent_app_number] => 10802574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347498 [patent_doc_number] => 20040248080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Methods for screening HIF like ouabain-resistant Na+-K+-ATPase agents' [patent_app_type] => new [patent_app_number] => 10/803185 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6031 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248080.pdf [firstpage_image] =>[orig_patent_app_number] => 10803185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171246 [patent_doc_number] => 20070071677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Non-toxic membrane-translocating peptides' [patent_app_type] => utility [patent_app_number] => 10/548438 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13807 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20070071677.pdf [firstpage_image] =>[orig_patent_app_number] => 10548438 [rel_patent_id] =>[rel_patent_doc_number] =>)